MedAvante-ProPhase Revenue and Competitors

Mercerville, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • MedAvante-ProPhase's estimated annual revenue is currently $50.7M per year.(i)
  • MedAvante-ProPhase's estimated revenue per employee is $201,000

Employee Data

  • MedAvante-ProPhase has 252 Employees.(i)
  • MedAvante-ProPhase grew their employee count by -11% last year.

MedAvante-ProPhase's People

NameTitleEmail/Phone
1
VP Business OperationsReveal Email/Phone
2
VP, Clinical SolutionsReveal Email/Phone
3
VP, Clinical OperationsReveal Email/Phone
4
Executive Administrative Assistant To Chief Commercial Officer and Business Development TeamReveal Email/Phone
5
VP, Clinical ScienceReveal Email/Phone
6
Senior Director Software EngineeringReveal Email/Phone
7
Director, eForms ServicesReveal Email/Phone
8
Senior Director, eCOA & eLearningReveal Email/Phone
9
Director, Clinical Data AnalyticsReveal Email/Phone
10
Associate Director, Information & Network Security, IT InfrastructureReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is MedAvante-ProPhase?

MedAvante-ProPhase is the leading global provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders with more than a decade of experience improving clinician-reported diagnostic and outcome measurements. MedAvante-ProPhase standardizes rating scale administration and scoring with the Virgil® Investigative Study Platform, a powerful approach to signal detection that puts the advantages of our experience in the hands of site raters as a tablet computer with unique context-sensitive electronic rating scale forms and study-specific clinical guidance, designed by clinicians for clinicians. We prepare and qualify clinical raters with effective, measurable rater training, and we assure ongoing data quality with Independent Review, over-read of assessment outcomes by expert central clinicians. Maximal protection against the risk of inconclusive results is delivered by MedAvante-ProPhase Independent Ratings, which in addition to standardizing scale administration and scoring avoids critical sources of perception bias that may block signal detection. Continuously trained and standardized remote Expert Clinicians are blind to protocol details and subject history, immune to the confounding impact of repeated contact with patients and free of pressure to enroll subjects. Independent Ratings have been used in more than 57 major trials completed to date. Supported by operations teams in the US, Germany, Russia and Japan, MedAvante-ProPhase delivers services for clinical trials in more than 40 countries worldwide. For more information, please visit www.medavante.com.

keywords:N/A

N/A

Total Funding

252

Number of Employees

$50.7M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MedAvante-ProPhase News

2022-04-20 - Global Cognitive Assessment and Training Market 2022-2028 ...

Cambridge Cognition; MedAvante-Prophase; Signant Health; Cogstate; Philps; Quest Diagnostics; ERT; Pearson; Total Brain; CogniFit...

2022-04-17 - US Cognitive Assessment Market Overview by Recent ...

... Assessment Market Overview by Recent Opportunities, Growth Size, Regional Analysis, and Forecasts to 2030 | Medavante-ProPhase, VeraSci,...

2022-04-17 - US Cognitive Assessment Market Overview by Recent ...

... Growth Size, Regional Analysis, and Forecasts to 2030 | Medavante-ProPhase, VeraSci, Lumos Labs, Signant Heath, ImPACT Applications...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$85M4690%N/A